摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(2'-deoxy-β-D-ribofuranosyl)-6-(4-methoxyphenyl)-2,3-dihydrofuro[2,3-d]pyrimidin-2(3H)-one

中文名称
——
中文别名
——
英文名称
3-(2'-deoxy-β-D-ribofuranosyl)-6-(4-methoxyphenyl)-2,3-dihydrofuro[2,3-d]pyrimidin-2(3H)-one
英文别名
3-(2'-deoxy-β-D-ribofuranosyl)-6-(4-methoxyphenyl)-2,3-dihydrofuro-[2,3-d]pyrimidin-2-one;3-(2'-deoxy-ribofuranosyl)-6-(4-methoxyphenyl)-2,3-dihydrofuro[2,3-d]pyrimidin-2-one;3-(4-Hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-6-(4-methoxy-phenyl)-3H-furo[2,3-d]pyrimidin-2-one;3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(4-methoxyphenyl)furo[2,3-d]pyrimidin-2-one
3-(2'-deoxy-β-D-ribofuranosyl)-6-(4-methoxyphenyl)-2,3-dihydrofuro[2,3-d]pyrimidin-2(3H)-one化学式
CAS
——
化学式
C18H18N2O6
mdl
——
分子量
358.351
InChiKey
ULCCSZONNMALEU-NUEKZKHPSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.1
  • 重原子数:
    26
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    101
  • 氢给体数:
    2
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • A <i>p</i>-[<sup>18</sup>F]Fluoroethoxyphenyl Bicyclic Nucleoside Analogue as a Potential Positron Emission Tomography Imaging Agent for Varicella-Zoster Virus Thymidine Kinase Gene Expression
    作者:Satish K. Chitneni、Christophe M. Deroose、Jan Balzarini、Rik Gijsbers、Sofie Celen、Zeger Debyser、Luc Mortelmans、Alfons M. Verbruggen、Guy M. Bormans
    DOI:10.1021/jm700971p
    日期:2007.12.27
    We recently reported a new positron emission tomography (PET) reporter gene, namely, varicella-zoster virus thymidine kinase (VZV-tk) in combination, with carbon-11 or fluorine-18 labeled m-alkoxyphenyl bicyclic nucleoside analogues (BCNAs) as PET reporter probes. We now report the synthesis and evaluation of p-alkoxyphenyl-BCNA tracers ([11C]-4 and [18F]-5), which are found to be superior to the m-alkoxyphenyl-BCNA
    我们最近报道了一个新的正电子发射断层扫描(PET)报告基因,即痘-带状疱疹病毒胸苷激酶(VZV-tk)与碳11或18标记的间烷氧基苯基双环核苷类似物(BCNA)组合使用记者调查。现在,我们报告了对-烷氧基苯基-BCNA示踪剂的合成和评估([11C] -4和[18F] -5),发现它们优于间烷氧基苯基-BCNA示踪剂。特别是,18标记的示踪剂([18F] -5,IC50为4.2 microM)在VZV-tk表达细胞中比以前报道的间甲氧基苯BCNA显示更高的积累。通过将苯酚前体3分别与作为烷基化剂的11CH 3I和18FCH 2CH 2Br加热来合成[11C] -4和[18F] -5。在293T细胞中对[11C] -4和[18F] -5进行的体外评估显示,其摄取量增加了约14倍和54倍,与对照细胞相比,它们分别进入了VZV-tk基因转导的细胞。LC-MS分析证实,VZV TK催化形成5
  • Novel water-soluble phosphatriazenes: versatile ligands for Suzuki–Miyaura, Sonogashira and Heck reactions of nucleosides
    作者:Shatrughn Bhilare、Vijay Gayakhe、Ajaykumar V. Ardhapure、Yogesh S. Sanghvi、Carola Schulzke、Yulia Borozdina、Anant R. Kapdi
    DOI:10.1039/c6ra19039a
    日期:——
    complexation reactions with Pd(OAc)2 and utilized for catalyzing column-free Suzuki–Miyaura cross-coupling of various purine and pyrimidine halonucleosides in water. The water-solubility of the catalytic system simplified the isolation of the cross-coupled products to mere filtration, while the catalytically active solution in the filtrate was recycled eight times. A novel copper-free Sonogashira coupling
    两种新的溶性三氮烯配体已被合成为与Pd(OAc)2络合反应的通用配体,并用于催化中各种嘌呤嘧啶卤代核苷的无柱铃木-宫浦交叉偶联。催化系统的溶性简化了交叉偶合产物的分离,使其仅需过滤,而滤液中的催化活性溶液则循环了八次。通过一锅合成FV-100(一种基于核苷的药物,用于带状疱疹或带状疱疹治疗的3期临床试验),也已建立了针对核苷的新型无Sonogashira偶联方案。通过另一种抗病毒药物:BVDU的合成证明了Heck反应的应用。
  • ANTI-VIRAL PYRIMIDINE NUCLEOSIDE ANALOGUES
    申请人:MCGUIGAN Christopher
    公开号:US20110015147A1
    公开(公告)日:2011-01-20
    A compound of formula (I) wherein Ar can be one six-membered or two fused six-membered aromatic rings; R 8 and R 9 can be hydrogen, alkyl, cycloalkyl, halogens, amino, alkylamino, dialkylamino, nitro, cyano, alkyoxy, aryloxy, thiol, alkylthiol, arythiol, or aryl; Q can be O, S or CY 2 , where Y may be H, alkyl or halogens; X can be O, NH, S, N-alkyl, (CHR 2 ) m where m is 1 to 10, and CY 2 ; Z can be O, S, NH, or N-alkyl; U″ is H and U′ can be H or CH 2 ; wherein: T can be OH, H, halogens, O-alkyl, O-acyl, O-aryl, CN, NH 2 . or N 3 ; T′ and T″ can be H or halogen; and W can be H or a phosphate group. Compounds show anti-viral activity, for example with respect to varicella zoster virus.
  • Anti-Viral Pyrimidine Nucleoside Analogues
    申请人:University College Cardiff Consultants Limited
    公开号:US20140011764A1
    公开(公告)日:2014-01-09
    A compound of formula (I) wherein Ar can be one six-membered or two fused six-membered aromatic rings; R 8 and R 9 can be hydrogen, alkyl, cycloalkyl, halogen, amino, alkylamino, dialkylamino, nitro, cyano, alkyoxy, aryloxy, thiol, alkylthiol, arythiol, or aryl; Q can be O, S or CY 2 , where Y may be H, alkyl or halogen; X can be O, NH, S, N-alkyl, (CHR 2 ) m where m is 1 to 10, and CY 2 ; Z can be O, S, NH, or N-alkyl; U″ is H and U′ can be H or CH 2; wherein: T can be OH, H, halogen, O-alkyl, O-acyl, O-aryl, CN, NH 2 or N 3 ; T′ and T″ can be H or halogen; and W can be H or a phosphate group. Compounds show anti-viral activity, for example with respect to varicella zoster virus.
  • US7820631B2
    申请人:——
    公开号:US7820631B2
    公开(公告)日:2010-10-26
查看更多

同类化合物

呋喃并[2,3-d]嘧啶-4(1H)-酮 呋喃并[2,3-d]嘧啶-2(3H)-酮 呋喃并[2,3-d]嘧啶 6-苯基呋喃并[2,3-D]嘧啶-4-胺 6-甲基呋喃并[2,3-d]嘧啶-4-胺 6-甲基呋喃并[2,3-d]嘧啶-4(3H)-酮 6-(4-甲氧基苯基)呋喃并[2,3-d]嘧啶-4-胺 6-(4-甲氧基苯基)-5-(3-吡啶)-呋喃并[2,3-d]嘧啶-4-胺 6-(4-甲基苯基)-呋喃并[2,3-d]嘧啶-4-胺 6-(4-溴-苯基)-4-氯-呋喃并[2,3-d]嘧啶 6-(4-氯苯基)-呋喃并[2,3-d]嘧啶-4-胺 6-(3-溴-苯基)-4-氯-呋喃并[2,3-d]嘧啶 6-(3-吡啶)-呋喃并[2,3-d]嘧啶-4-胺 5-甲基呋喃并[2,3-d]嘧啶-4-胺 5-溴呋喃并[2,3-D]嘧啶-4-胺 5-氯甲基呋喃并[2,3-d]嘧啶-2,4-二胺 5,6-二甲基呋喃[2,3-d]嘧啶-4-胺 4-氯呋喃[2,3-D]嘧啶 4-氯-6-甲基-呋喃并[2,3-d]嘧啶 4-氨基呋喃并[2,3-D]嘧啶 4,6-二甲基呋喃并[2,3-d]嘧啶 4,6-二甲基呋喃并[2,3-D]嘧啶-2-胺 3-(2-脱氧-beta-D-赤式-呋喃戊糖基)-6-甲基呋喃并[2,3-d]嘧啶-2(3H)-酮 2-甲基硫代呋喃并[2,3-d]嘧啶-6-甲醇 2,4-二氯呋喃并[2,3-d]嘧啶 2,4-二氯-5-甲基呋喃并[2,3-d]嘧啶 2-Methyl-4-diacetylamino-5,6-bis-(2-furyl)furo<2,3-d>pyrimidine 3-[1-methyl-6-(5-nitro-furan-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-ylamino]-propan-1-ol 1-Methyl-4-(1-methyl-2-methoxy-ethyl-amino)-6-(5-nitro-2-furyl)-1H-pyrazolo<3.4-d>pyrimidin 2-Ethyl-4-amino-5,6-bis-(2-furyl)furo<2,3-d>pyrimidine 3-[3’,5’-di-O-(tert-butyldimethylsilyl)-2’-deoxy-β-D-ribofuranosyl]-6-(p-pentylphenyl)-2,3-dihydrofuro[2,3-d]pyrimidin-2-one 2,6-dimethyl-3H-furo[2,3-d]pyrimidine-4-thione 4-hydrazino-6-methyl-2-phenyl-furo[2,3-d]pyrimidine 3-[3'-O-(tert-butyldimethylsilyl)-2'-deoxy-β-D-ribofuranosyl]-6-(p-pentylphenyl)-2,3-dihydrofuro[2,3-d]pyrimidin-2-one 4-Ethylamino-6-methylfuro<4,5-b>pyrimidin 6-[Diethoxy(oxido)phosphaniumyl]furo[2,3-d]pyrimidine t counted 4-methoxy-2,6-dimethyl-furo[2,3-d]pyrimidine 3-(2-deoxy-β-D-erythro-pentofuranosyl)-6-ethynyl-furo[2,3-d]pyrimidin-2(3H)-one ethyl (4-oxo-5-phenyl-3,4-dihydrofuro[2,3-d]pyrimidin-2-yl)acetate 2,2'-[3-methyl-6-(5-nitro-furan-2-yl)-isoxazolo[5,4-d]pyrimidin-4-ylazanediyl]-bis-ethanol 5-[(R/S)-2-(2'-methoxyphenyl)pentyl]furo[2,3-d]pyrimidine-2,4-diamine 5-acetyl-6-(benzyloxy)-2,4-dimethylfuro<2,3-b>pyridine 5-[(R/S)-2-(2'-methoxyphenyl)-3-methylbutyl]furo[2,3-d]-pyrimidine-2,4-diamine furan-2-carboxylic acid N'-{2-amino-7-[2-(t-butyldimethylsilanyloxy)ethyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}-hydrazide 2-(5-phenylfuro[2,3-d]pyrimidin-4-ylamino)ethanol 5-[(R/S)-2-(2'-methoxyphenyl)-4-methylpentyl]furo[2,3-d]pyrimidine-2,4-diamine 5-[(R/S)-2-(2'-methoxyphenyl)hexyl]furo[2,3-d]pyrimidine-2,4-diamine tert-butyl 3-<6'-(benzyloxy)-2',4'-dimethylfuro<2,3-b>-pyrid-5'-yl>-3-hydroxybutanoate 6-(benzyloxy)-2,4-dimethylfuro<2,3-b>pyridine-5-carboxaldehyde